Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04594096 · ClinicalTrials.gov registry record · NA

Improving Treatment-Related Symptom Management in Adolescents and Young Adults With Cancer

A NA study of Cancer, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04594096: Completed NA study of Cancer, sponsored by University of California, Davis.

NCT04594096 is a NA study of Cancer that has completed, run by University of California, Davis. The registered enrollment target is 20 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04594096, a NA study of Cancer, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will test the acceptability and feasibility of a telehealth intervention to improve communication between patients and medical providers in adolescent and young adult (AYA) cancer patients receiving chemotherapy treatment.

Primary Outcome

\>65% of enrolled patients will complete the trial

Conditions Studied

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL Telehealth visits

Study Locations (1)

California

  • Comprehensive Cancer Center - Sacramento

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-09-30
Est. Completion 2023-12-31
Phase NA
University of California, Davis

657 total trials

What the finished NCT04594096 record still lists

NCT04594096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT04594096 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04594096 about?

NCT04594096 is a clinical study titled "Improving Treatment-Related Symptom Management in Adolescents and Young Adults With Cancer". This study will test the acceptability and feasibility of a telehealth intervention to improve communication between patients and medical providers in adolescent and young adult (AYA) cancer patients receiving chemotherapy treatment.

What is the current status of trial NCT04594096?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-09-30. Estimated completion is 2023-12-31.

What conditions does trial NCT04594096 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT04594096?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Telehealth visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT04594096?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04594096 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04594096's enrollment target sits among peer trials

20 561st of 615 higher than 47 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04594096, the US trial registry maintained by the National Library of Medicine. NCT04594096 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.